Telcagepant is a calcitonin gene-related peptide receptor antagonist which was an investigational drug for the acute treatment and prevention of migraine, developed by Merck & Co.In the acute treatment of migraine, it was found to have equal efficacy to rizatriptan and zolmitriptan. Wikipedia